Combined magnetic resonance and optical imaging of head and neck tumor xenografts using Gadolinium-labelled phosphorescent polymeric nanomicelles

Head and Neck Oncology

Volumn 2, Issue 1, 2010, Pages

  Kumar, Rajiv ^a,d   Ohulchanskyy, Tymish Y ^a   Turowski, Steve G ^b   Thompson, Mark E ^c   Seshadri, Mukund ^b   Prasad, Paras N ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; NANOPARTICLE; POLYMER; TETRAPHENYLTETRANAPHTHOPORPHYRIN; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; LUMINESCENT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; MOUSE; NANOIMAGING; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; OPTICAL INSTRUMENTATION; PARTICLE SIZE; PHOSPHORESCENCE; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR XENOGRAFT; ANIMAL; BIOLOGICAL MODEL; CARCINOMA; EVALUATION; HEAD AND NECK TUMOR; METABOLISM; METHODOLOGY; MICELLE; MOUSE MUTANT; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; XENOGRAFT;

ANIMALS; CARCINOMA; FEMALE; GADOLINIUM; HEAD AND NECK NEOPLASMS; HUMANS; LUMINESCENT AGENTS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MICE, SCID; MICELLES; MODELS, BIOLOGICAL; NANOPARTICLES; NEOPLASMS, SQUAMOUS CELL; OPTICAL DEVICES; POLYMERS; SPECTROSCOPY, NEAR-INFRARED; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 78649332561     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-2-35     Document Type: Article

References (21)

1. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update. J Bernier, Curr Opin Oncol 2008 20 249 255 Review 10.1097/CCO.0b013e3282faa0b1 18391622
2. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. C Scully J Bagan, Oral Dis 2009 15 6 388 99 10.1111/j.1601-0825.2009.01563.x 19371401
3. Nanoplatforms for targeted molecular imaging in living subjects. W Cai X Chen, Small 2007 3 1840 1854 10.1002/smll.200700351 17943716
4. Nanoparticle therapeutics: an emerging treatment modality for cancer. ME Davis ZG Chen DM Shin, Nat Rev Drug Discov 2008 7 771 782 10.1038/nrd2614 18758474
5. Nanocarriers as an emerging platform for cancer therapy. D Peer JM Karp S Hong O Farokhzad R Margalit R Langer, Nat Nanotechnol 2007 2 751 760 10.1038/nnano.2007.387 18654426
6. Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenografts. M Seshadri M Merzianu H Tang NR Rigual M Sullivan TR Loree SR Popat EA Repasky BL Hylander, Cancer Biol Ther 2009 8 2275 2283 19829072
7. Near-infrared phosphorescent polymeric nanomicelles: efficient optical probes for tumor imaging and detection. R Kumar TY Ohulchanskyy I Roy SK Gupta C Borek ME Thompson PN Prasad, ACS Appl Mater Interfaces 2009 1 1474 1481 10.1021/am9001293 20355951
8. Core-cross-linked polymeric micelles as paclitaxel carriers. X Shuai T Merdan AK Schaper F Xi T Kissel, Bioconjug Chem 2004 15 441 448 10.1021/bc034113u 15149170
9. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Y Matsumura K Kataoka, Cancer Sci 2009 100 572 579 10.1111/j.1349-7006.2009.01103.x 19462526
10. Renal clearance of quantum dots. HS Choi W Liu P Misra E Tanaka JP Zimmer BI Ipe MG Bawendi JV Frangioni, Nat Biotechnol 2007 25 1165 1170 10.1038/nbt1340 17891134
11. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. V Ntziachristos C Bremer R Weissleder, Eur Radiol 2003 13 195 208 12541130
12. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. L Josephson MF Kircher U Mahmood Y Tang R Weissleder, Bioconjug Chem 2002 13 554 560 10.1021/bc015555d 12009946
13. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. H Choi SR Choi R Zhou HF Kung IW Chen, Acad Radiol 2004 11 996 1004 10.1016/j.acra.2004.04.018 15350580
14. Dendrimer-Based Nanoprobe for Dual Modality Magnetic Resonance and fluorescence imaging. VS Talanov CAS Regino H Kobayashi M Bernardo PL Choyke MW Brechbiel, Nano Lett 2006 6 1459 1463 10.1021/nl060765q 16834429
15. Gadolinium-labeled quantum dots for molecular magnetic resonance imaging: R1 versus R2 mapping. M Oostendorp K Douma TM Hackeng MJ Post MA van Zandvoort WH Backes, Magn Reson Med 2010 64 291 298 10.1002/mrm.22342 20572132
16. Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping. MP Melancon Y Wang X Wen JA Bankson LC Stephens S Jasser JG Gelovani JN Myers C Li, Invest Radiol 2007 42 569 578 10.1097/RLI.0b013e31804f5a79 17620940
17. Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia. N Nitin KJ Rosbach A El-Naggar M Williams A Gillenwater RR Richards-Kortum, Neoplasia 2009 11 542 551 19484143
18. Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. JP Gleysteen RD Duncan JS Magnuson JB Skipper K Zinn EL Rosenthal, Cancer Biol Ther 2007 6 1181 1185 17637562
19. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned? JC Weinreb AK Abu-Alfa, J Magn Reson Imaging 2009 30 1236 1239 10.1002/jmri.21979 19938035
20. Nanotechnology in head and neck cancer: the race is on. IH El-Sayed, Curr Oncol Rep 2010 12 121 128 Review 10.1007/s11912-010-0087-2 20425597
21. Synthesis and selective tumor targeting properties of water soluble porphyrin-Pt(II) conjugates. R Song YS Kim YS Sohn, J Inorg Biochem 2002 89 83 88 10.1016/S0162-0134(01)00413-5 11931967